analyst
PR
NASDAQ · PRME
Prime Medicine, Inc.
Healthcare · Biotechnology
$3.81
Down-$0.08 (-2.10%)
Updated Oct 22, 2026, 11:20 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 754.01M
- P/E ratio
- -3.46
- Dividend yield
- 0.00%
- 52-week range
- $2.67 – $4.83
- Volume
- 2.44M
- Avg. volume
- 3.98M
Price performance · PRME
PRME price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 21, 2026
PRME closed at $3.81 after 21 trading sessions, up 21.73% for the selected period.
- Last close
- $3.81
- Period change
- +21.73%
- Period low
- $2.88
- Period high
- $3.99
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 21, 2026 | $3.92 | $4.005 | $3.795 | $3.81 | 2.44M |
| Oct 20, 2026 | $3.75 | $4.05 | $3.73 | $3.92 | 3.69M |
| Oct 19, 2026 | $3.56 | $3.87 | $3.49 | $3.83 | 4.25M |
| Oct 16, 2026 | $3.55 | $3.605 | $3.41 | $3.47 | 4.39M |
| Oct 15, 2026 | $3.12 | $3.65 | $3.06 | $3.61 | 6.3M |
| Oct 14, 2026 | $3.21 | $3.22 | $3.045 | $3.13 | 4.24M |
| Oct 13, 2026 | $3.61 | $3.61 | $3.27 | $3.32 | 4.06M |
| Oct 12, 2026 | $3.95 | $3.965 | $3.58 | $3.61 | 3.14M |
| Oct 9, 2026 | $3.57 | $4.14 | $3.54 | $3.99 | 8.07M |
| Oct 8, 2026 | $3.83 | $3.8984 | $3.52 | $3.58 | 7.73M |
| Oct 7, 2026 | $3.36 | $4.02 | $3.3001 | $3.90 | 11.2M |
| Oct 6, 2026 | $3.56 | $3.7176 | $3.26 | $3.50 | 12.02M |
| Oct 5, 2026 | $3.00 | $3.26 | $2.88 | $3.21 | 4.72M |
| Oct 2, 2026 | $3.05 | $3.075 | $2.92 | $2.98 | 2.11M |
| Oct 1, 2026 | $3.05 | $3.105 | $2.98 | $2.99 | 2.83M |
| Sep 30, 2026 | $3.11 | $3.19 | $3.02 | $3.055 | 3.13M |
| Sep 29, 2026 | $2.93 | $3.135 | $2.88 | $3.09 | 3.61M |
| Sep 28, 2026 | $2.85 | $2.92 | $2.77 | $2.875 | 3.68M |
| Sep 25, 2026 | $3.42 | $3.44 | $2.875 | $2.90 | 7.12M |
| Sep 24, 2026 | $3.11 | $3.13 | $2.9901 | $3.07 | 4.49M |
| Sep 23, 2026 | $3.53 | $3.53 | $3.12 | $3.13 | 3.33M |
Latest PRME news
The latest Smart Investors Daily articles mentioning PRME.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…